Mitchell Cancer Institute — Mobile, Alabama

Mitchell Cancer Institute is a clinical research site located in Mobile, Alabama, United States 36693.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Mitchell Cancer Institute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic, Lung Cancer.

Sponsors: Eli Lilly and Company, Carevive Systems, Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mitchell Cancer Institute?

Mitchell Cancer Institute has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mitchell Cancer Institute conducted?

Mitchell Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic, Lung Cancer.

Is Mitchell Cancer Institute accredited by Crixeo Health?

Mitchell Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mitchell Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.